EP Patent

EP2082765A1 — Inhaler

Assigned to Boehringer Ingelheim International GmbH · Expires 2009-07-29 · 17y expired

What this patent protects

An inhaler (1) for delivery of a powder-form inhalation formulation from a blister strip (2) with a plurality of blister pockets (3) is proposed, A flexible guiding element (20) receives the used blisters strip.

USPTO Abstract

An inhaler (1) for delivery of a powder-form inhalation formulation from a blister strip (2) with a plurality of blister pockets (3) is proposed, A flexible guiding element (20) receives the used blisters strip.

Drugs covered by this patent

Patent Metadata

Patent number
EP2082765A1
Jurisdiction
EP
Classification
—
Expires
2009-07-29
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.